1.Growth inhibitory effects of recombinant granzyme B containing different N-terminal translocating peptides.
Jing ZHAO ; Zhi WANG ; Cui-Juan YU ; Yun-Xin CAO ; Li ZHANG ; Cheng-Ji WANG ; An-Gang YANG
Chinese Journal of Biotechnology 2004;20(4):501-506
Translocating protein and translocating peptides have therapeutic potential against tumors by exposing the cytotoxic domains of toxic proteins to the cell cytosol. The aim of this study is to investigate the effect of N-terminally fused PE translocating peptides on granzyme B (GrBa) activity. PE II-GrBa fusion protein genes were constructed by replacing N-terminal signal and acidic dipeptide sequence of human granzyme B gene with two truncated translocating sequences of Pseudomonas exotoxin A (PE II aa 280-364/358) by recombinant PCR, and then cloned into pIND inducible expression vector. The resulting pIND-PE II-GrBa expression vectors were co-transfected with assistant plasmid pVgRXR into HeLa cells through lipofectamine, followed by selection on G418 and zeocin. The resistant cells were collected and induced with ponasterone A. Western blot analysis demonstrated that ponasterone A induction caused the expression of PE II-GrBa fusion proteins, and indirect immunofluorescence detected giant sized multinucleated cells, suggesting cytoskeletal and mitotic abnormalities as reported in our previous studies. Western blot, enzymatic activity assay and cell counting analysis indicated that two types of PE II-GrBa fusion proteins were capable of cleaving both endogenous and exogenous substrates of granzyme B, and inhibiting the growth of cells. The PE II (aa 280-358)-GrBa was shown to have higher serine protease activity and stronger growth inhibitory effect. Such inhibition was presumably associated with G2 arrest as determined by cell cycle analysis. These data prove that PE II-GrBa fusion proteins have cell inhibitory effect similar to GrBa, and that the shorter PE-derived peptide exerts less influence on GrBa activity. This study helps to optimize the construction of recombinant protein comprising translocating peptides and cytotoxic molecules for tumor cell killing.
ADP Ribose Transferases
;
genetics
;
pharmacology
;
Bacterial Toxins
;
genetics
;
pharmacology
;
Cell Proliferation
;
drug effects
;
Exotoxins
;
genetics
;
pharmacology
;
Granzymes
;
genetics
;
pharmacology
;
HeLa Cells
;
Humans
;
Recombinant Fusion Proteins
;
pharmacology
;
Virulence Factors
;
genetics
;
pharmacology
2.Type III secretion study of popN- mutant of Pseudomonas aeruginosa and proteases degradation.
Hong-Jiang YANG ; Dong-Sheng WEI ; Ming-Chun LI ; Lai-Jun XING
Chinese Journal of Biotechnology 2007;23(5):846-851
Pseudomonas aeruginosa is an important opportunistic human pathogen. It encodes many virulence factors and one of them is type III secretion system (TTSS). Effectors proteins can be delivered into host cells directly by this system, causing necrosis or apoptosis. popN gene is the first gene in the popN operon of TTSS gene cluster. To investigate its function, popN gene deletion mutant was generated in this study, and we found this mutant can secrete effectors proteins constitutively under non-inducting condition in DMEM medium containing serum. The results indicated that PopN is a negative regulator of the TTSS expression. However, no secreted effector proteins were detectable when the popN- mutant was grown in LB medium under non-inducting condition. To investigate the possible reasons, effects of growth status and protease (s) inhibitors on the TTSS were investigated. We present evidences that indicate protease mediated degradation of secreted effector proteins played a key role in the phenotypic inconsistency of popN- mutant.
ADP Ribose Transferases
;
metabolism
;
secretion
;
Bacterial Proteins
;
genetics
;
metabolism
;
secretion
;
Bacterial Toxins
;
metabolism
;
Gene Expression Regulation, Bacterial
;
Mutation
;
Peptide Hydrolases
;
genetics
;
metabolism
;
Pore Forming Cytotoxic Proteins
;
genetics
;
secretion
;
Protease Inhibitors
;
pharmacology
;
Pseudomonas aeruginosa
;
genetics
;
metabolism
;
pathogenicity
3.Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin.
Hui YANG ; Dan HE ; Kai CHAO ; Qing LIN ; Song YOU ; Hua-Liang HUANG
Chinese Journal of Biotechnology 2004;20(3):348-351
A recombinant immunotoxin named CEA/PE38/KDEL was constructed, which was composed of anti-CEA single-chain Fv and the truncated and modified form of Pseudomonas exotoxin (PE38/KDEL). The CEA/PE38/KDEL immunotoxin was expressed in the E. coli strain BL21 (DE3)-star as inclusion bodies. The denatured inclusion bodies were purified with Ni-NTA chelate agarose, then the constant gradient dialysis was used to perform the refolding of the CEA/PE38/KDEL immunotoxin. Results of FACS and MTT assay indicate that the refolded immunotoxins keep potent and specific cytotoxicity to tumor cells bearing CEA antigens.
ADP Ribose Transferases
;
biosynthesis
;
genetics
;
pharmacology
;
Antibodies
;
genetics
;
metabolism
;
pharmacology
;
Antineoplastic Agents
;
metabolism
;
pharmacology
;
Bacterial Toxins
;
biosynthesis
;
genetics
;
pharmacology
;
Carcinoembryonic Antigen
;
immunology
;
Cloning, Molecular
;
Escherichia coli
;
genetics
;
metabolism
;
Exotoxins
;
biosynthesis
;
genetics
;
pharmacology
;
Humans
;
Immunoglobulin Fragments
;
biosynthesis
;
genetics
;
Immunotoxins
;
genetics
;
isolation & purification
;
metabolism
;
pharmacology
;
Protein Renaturation
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
pharmacology
;
Virulence Factors
;
biosynthesis
;
genetics
;
pharmacology
4.Creation and anti-cancer potency in HeLa cells of a novel chimeric toxin, HMGNCIDIN, composed of HMGN2 a-helical domain and PE38 KDEL domain III.
Wen-bi XIONG ; Ning HUANG ; Yun FENG ; Qi WU ; Bo-yao WANG
Chinese Medical Journal 2008;121(1):82-85
ADP Ribose Transferases
;
chemistry
;
pharmacology
;
Animals
;
Antineoplastic Agents
;
pharmacology
;
Bacterial Toxins
;
chemistry
;
pharmacology
;
Exotoxins
;
chemistry
;
pharmacology
;
Female
;
HMGN2 Protein
;
chemistry
;
pharmacology
;
HeLa Cells
;
Humans
;
Immunotoxins
;
pharmacology
;
Mice
;
Mice, Inbred BALB C
;
Protein Structure, Tertiary
;
Recombinant Fusion Proteins
;
biosynthesis
;
pharmacology
;
Virulence Factors
;
chemistry
;
pharmacology
5.A strategy for targeting gene therapy against cancer mediated by epidermal growth factor receptor.
Hua-Sheng FANG ; Mei HONG ; Shu-Zheng ZHANG ; Sheng-Dong LU
Acta Academiae Medicinae Sinicae 2004;26(6):661-665
OBJECTIVETo establish a protocol for the targeting gene therapy against cancer with rich epidermal growth factor receptor (EGFR).
METHODSA recombinant pcDNA3.1-PE III mut was constructed and combined with a non-viral vector, a fusion protein histone H1, epidermal growth factor C-loop previously expressed by us, to be a protein-DNA complex in vitro. Using the complex to treat BT-325 and Hela cancer cells with EGFR and JK cells without EGFR. The killing rates of the cells was calculated after 48 h of incubation at 37 degrees C.
RESULTSTo BT-325 and Hela cells, the killing rates were 46.03% and 48.12% respectively. To JK cells, the complex had no killing function.
CONCLUSIONThe protocol for targeting gene therapy against cancer with EGFR has been established successfully.
ADP Ribose Transferases ; genetics ; pharmacology ; Bacterial Toxins ; genetics ; pharmacology ; Base Sequence ; Cell Line, Tumor ; Cells ; DNA ; genetics ; Exotoxins ; genetics ; pharmacology ; Gene Targeting ; Genetic Therapy ; Genetic Vectors ; Histones ; genetics ; Humans ; Molecular Sequence Data ; Receptor, Epidermal Growth Factor ; genetics ; metabolism ; Recombinant Fusion Proteins ; genetics ; metabolism ; pharmacology ; Transfection ; Virulence Factors ; genetics ; pharmacology
6.Biochemical and physical properties for a recombinant IL6 Pseudomonas exotoxin fusion protein IL6D24-PE40KDEL.
Jian-Wu CUI ; Si-Qi GUO ; Yu-Ying SUN ; Nan LIU ; Fei LIANG ; Yong-Zhi XI
Journal of Experimental Hematology 2004;12(6):825-828
The objective was to identify some biochemical and physical properties for fusion protein IL6D24-PE40KDEL. Edman degradation, SDS-PAGE, peptide mass fingerprinting, Western blot and MTT were used for identification of the protein. The results showed that the sequence of N-terminus is Met-Ile-Asp-Lys-Gln-Ile, Met was added because of prokaryotic expression system; Western blot revealed that the purified protein could react with IL6 and PEA antibody. The purified protein IL6D24-PE40KDEL could kill the multiple myeloma cell lines U266 expressing high affinity IL6R, but it could not kill the cell lines CEM which not expressed IL6R; The molecular weight was 58.7 kD measuring by SDS-PAGE; peptide mass fingerprinting (PMF) confirmed that the construction of IL6D24-PE40KDEL was correct. A novel protein by Peptident database in EXPASY web site was identified. In conclusion, IL6D24-PE40KDEL is a new targeting protein with bioactivity of specific killing effect.
ADP Ribose Transferases
;
chemistry
;
metabolism
;
pharmacology
;
Amino Acid Sequence
;
Blotting, Western
;
Cell Line, Tumor
;
Cell Survival
;
drug effects
;
Dose-Response Relationship, Drug
;
Exotoxins
;
chemistry
;
metabolism
;
pharmacology
;
Humans
;
Interleukin-6
;
chemistry
;
metabolism
;
pharmacology
;
Molecular Sequence Data
;
Pseudomonas aeruginosa
;
genetics
;
metabolism
;
Recombinant Fusion Proteins
;
chemistry
;
metabolism
;
pharmacology
;
Sequence Analysis, Protein
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
7.Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa.
Hye Hyun CHO ; Kye Chul KWON ; Semi KIM ; Sun Hoe KOO
Annals of Laboratory Medicine 2014;34(4):286-292
BACKGROUND: Pseudomonas aeruginosa is a clinically important pathogen that causes opportunistic infections and nosocomial outbreaks. Recently, the type III secretion system (TTSS) has been shown to play an important role in the virulence of P. aeruginosa. ExoU, in particular, has the greatest impact on disease severity. We examined the relationship among the TTSS effector genotype (exoS and exoU), fluoroquinolone resistance, and target site mutations in 66 carbapenem-resistant P. aeruginosa strains. METHODS: Sixty-six carbapenem-resistant P. aeruginosa strains were collected from patients in a university hospital in Daejeon, Korea, from January 2008 to May 2012. Minimum inhibitory concentrations (MICs) of fluoroquinolones (ciprofloxacin and levofloxacin) were determined by using the agar dilution method. We used PCR and sequencing to determine the TTSS effector genotype and quinolone resistance-determining regions (QRDRs) of the respective target genes gyrA, gyrB, parC, and parE. RESULTS: A higher proportion of exoU+ strains were fluoroquinolone-resistant than exoS+ strains (93.2%, 41/44 vs. 45.0%, 9/20; P< or =0.0001). Additionally, exoU+ strains were more likely to carry combined mutations than exoS+ strains (97.6%, 40/41 vs. 70%, 7/10; P=0.021), and MIC increased as the number of active mutations increased. CONCLUSIONS: The recent overuse of fluoroquinolone has led to both increased resistance and enhanced virulence of carbapenem-resistant P. aeruginosa. These data indicate a specific relationship among exoU genotype, fluoroquinolone resistance, and resistance-conferring mutations.
ADP Ribose Transferases/genetics
;
Anti-Bacterial Agents/*pharmacology
;
Bacterial Proteins/genetics
;
Bacterial Toxins/genetics
;
Carbapenems/pharmacology
;
Drug Resistance, Bacterial/*drug effects
;
Fluoroquinolones/*pharmacology
;
Genotype
;
Humans
;
Microbial Sensitivity Tests
;
Multilocus Sequence Typing
;
Mutation
;
Pseudomonas aeruginosa/*genetics/isolation & purification/pathogenicity
;
Sputum/microbiology
;
Virulence
8.Effects of Pseudomonas quinolone signal on the virulence of Pseudomonas aeruginosa.
Xiaohong FU ; Xuemei ZHANG ; Chunmei JING ; Lan LIU ; Yibing YIN ; Junru JIANG
Journal of Southern Medical University 2013;33(1):18-21
OBJECTIVETo investigate the effect of Pseudomonas quinolone signal (PQS) on the virulence of Pseudomonas aeruginosa.
METHODSPseudomonas aeruginosa strain PAO1 was treated with PQS alone, PQS plus farnesol, or farnesol alone. The transcriptional levels of the regulator gene ExsA and virulence protein gene ExoS of type III secretion system were examined using quantitative real-time PCR, and spectrophotometry was employed to detect pyocyanin production in the bacteria. The adhesion and invasiveness of the treated PAO1 in cultured alveolar epithelial cells A549 were assessed on plate count agar, and their effects on the survival of a mouse model of peritonitis was compared.
RESULTSThe increase or decrease of PQS did not affect the growth of PAO1. Compared with the untreated bacteria, PQS-treated PAO1 showed obviously increased transcription levels of ExsA and ExoS (P<0.01) and pyocyanin production, which was significantly lowered by farnesol (P<0.01). In A549 cell cultures, farnesol-treated PAO1 exhibited significantly lowered adhesion and invasiveness, while PQS-treated PAO1 caused a significantly decreased survival time of mice with peritonitis (P<0.01). Farnesol treatment did not obviously affected ExsA transcription (P>0.05) but caused a significant reduction in the transcriptional level of Exos (P<0.05) in PAO1. PQS showed no significant effect on the adhesion and invasiveness of PAO1 (P<0.05).
CONCLUSIONPQS can maintain the adhesion and invasiveness of Pseudomonas aeruginosa, and in the hosts of the bacteria, PQS concentration is positively correlated with pyocyanin production and hence negatively with the survival time of the hosts.
ADP Ribose Transferases ; genetics ; metabolism ; Animals ; Bacterial Adhesion ; Bacterial Proteins ; genetics ; metabolism ; Bacterial Toxins ; genetics ; metabolism ; Cell Line ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Peritonitis ; microbiology ; Pseudomonas aeruginosa ; genetics ; metabolism ; pathogenicity ; Quinolones ; pharmacology ; Recombinant Fusion Proteins ; genetics ; metabolism ; Signal Transduction ; Trans-Activators ; genetics ; metabolism ; Transcription, Genetic ; Virulence
9.Pseudomonas aeruginosa Exotoxin A Reduces Chemoresistance of Oral Squamous Carcinoma Cell via Inhibition of Heat Shock Proteins 70 (HSP70).
Sang Rye PARK ; Kyoung Duk LEE ; Uk Kyu KIM ; Young Gi GIL ; Kyu Seon OH ; Bong Soo PARK ; Gyoo Cheon KIM
Yonsei Medical Journal 2010;51(5):708-716
PURPOSE: Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9). MATERIALS AND METHODS: The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis. RESULTS: While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint. CONCLUSION: Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells.
ADP Ribose Transferases/*pharmacology
;
Antineoplastic Agents/*pharmacology
;
Apoptosis/drug effects
;
Bacterial Toxins/*pharmacology
;
Blotting, Western
;
Carcinoma, Squamous Cell/drug therapy/*metabolism
;
Cell Cycle/drug effects
;
Cell Line, Tumor
;
Chromatography, Liquid
;
Cyclin B/metabolism
;
Cyclin-Dependent Kinase 2/metabolism
;
Drug Resistance, Neoplasm/*drug effects
;
E2F1 Transcription Factor/metabolism
;
Electrophoresis
;
Exotoxins/*pharmacology
;
HSP70 Heat-Shock Proteins/genetics/*metabolism
;
Humans
;
In Situ Nick-End Labeling
;
Mouth Neoplasms/drug therapy/*metabolism
;
Tandem Mass Spectrometry
;
Tumor Suppressor Protein p53/metabolism
;
Virulence Factors/*pharmacology